fda ruling on tirzepatide today Grants a New Indication for Obesity Management FDA Update: Current Guidelines for

In addition, the follow-up duration of ELIXA was also relatively short (2.1 years), especially when compared with the follow-up duration of 5.4 years in the REWIND trial [60, 62]

Dr Fiona Willer, the president of Dietitians Australia, the peak body for dietitians and nutrition professionals, says weight loss medication in Australia must be prescribed alongside a referral to an accredited practising dietitian to ensure nutrition needs are supported

The agency is now proposing to the Ministry of Public Health that GLP-1 RAs be reclassified from a dangerous drug to a special controlled drug, which would restrict sales to licensed modern pharmacies only with a doctors prescription

Manufacturer copay cards, for example, can lower out-of-pocket expenses to as little as $25 per month for individuals with commercial insurance